Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Authors including 'HK'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Felsinger JMv, Lasagna L,... The response of normal men to lysergic acid derivatives (di- and mono-... J. Clin. Exper. Psyc... 1956
Oosterhuis HK Influence des médicaments psychotropes sur le métabolism cérébral. Re... Acta neurol. belg. 1961
Brown JH, Mackey HK, Rigg... A novel in vitro assay for anti-inflammatory agents based on stabiliza... Abstr. Papers, Amer.... 1966
Singh MP, Kalia CS, Jain ... Chromosomal aberrations induced in barley by LSD Science 1970
Beecher HK A physician's response to the psychedelic experience in the death enco... Psychedelic Review 1971
Frischknecht HR, Waser PG Actions of Hallucinogens on Ants (Formica Pratensis)-I. Brain Levels o... Gen Pharmacol. 1978
Frischknecht HR, Waser PG Actions of Hallucinogens on Ants (Formica Pratensis)-II. Effects of Am... Gen.Pharmacol. 1978
Frischknecht HR, Waser PG Actions of Hallucinogens on Ants (Formica Pratensis)-III. Social Behav... Gen.Pharmacol. 1980
Larson AA, Chinn C, Proud... Dual Actions of Lysergic Acid Diethylamide Tartrate (LSD), 2-Bromo-D-L... The Journal of Pharm... 1981
Tashkin DP, Coulson AH, C... Respiratory symptoms and lung function in habitual heavy smokers of ma... Am Rev Respir Dis 1987
Kulmala HK, Boja JW, Sche... Behavioral suppression following 3,4-methylenenedioxymethamphetamine Life Sci 1987
Francom P, Andrenyak D, L... Determination of LSD in urine by capillary column gas chromatography a... J Anal Toxicol 1988
Lim HK, Foltz RL In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine... Chem Res Toxicol 1988
Lim HK, Foltz RL Identification of metabolites of 3,4-(methylenedioxy)methamphetamine i... Chem Res Toxicol 1989
Lim HK, Foltz RL In vivo formation of aromatic hydroxylated metabolites of 3,4-(methyle... Biol Mass Spectrom 1991
Elayan I, Gibb JW, Hanson... Long-term alteration in the central monoaminergic systems of the rat b... Eur J Pharmacol 1992
Johnson M, Elayan I, Hans... Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphet... J Pharmacol Exp Ther 1992
Lim HK, Zeng S, Foltz RL Comparative investigation of disposition of 3,4-(methylenedioxy)metham... J Pharm Biomed Anal 1992
Elayan I, Gibb JW, Hanson... Short-term effects of 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymet... J Pharmacol Exp Ther 1993
Bohn M, Bohn G, Blaschke ... Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetam... Int J Legal Med 1993
Lim HK, Su Z, Foltz RL Stereoselective disposition: enantioselective quantitation of 3,4-(met... Biol Mass Spectrom 1993
Kramer HK, Poblete JC, Az... 3,4-Methylenedioxymethamphetamine ('Ecstasy') promotes the translocati... Brain Res 1995
Reid LD, Hubbell CL, Tsai... Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhan... Pharmacol Biochem Be... 1995
Reid LD, Hubbell CL, Tsai... Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhan... Pharmacol Biochem Be... 1996
Ensslin HK, Kovar KA, Mau... Toxicological detection of the designer drug 3,4-methylenedioxyethylam... J Chromatogr B Biome... 1996
Frost M, Kohler H, Blasch... Analysis of 'Ecstasy' by capillary electrophoresis Int J Legal Med 1996
Spitzer M, Thimm M, Herml... Increased activation of indirect semantic associations under psilocybi... Biol Psychiatry 1996
Kramer HK, Poblete JC, Az... Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetam... Neuropsychopharmacol... 1997
Ensslin HK, Maurer HH, Go... Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Is... Drug Metab Dispos 1997
Gibb JW, Johnson M, Elaya... Neurotoxicity of amphetamines and their metabolites NIDA Res Monogr 1997
Matthias P, Tashkin DP, M... Effects of varying marijuana potency on deposition of tar and delta9-T... Pharmacol Biochem Be... 1997
Kramer HK, Poblete JC, Az... Characterization of the translocation of protein kinase C (PKC) by 3,4... Neuropsychopharmacol... 1998
Fleckenstein AE, Haughey ... Differential effects of psychostimulants and related agents on dopamin... Eur J Pharmacol 1999
Chang L, Grob C, Ernst T,... Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebr... Psychiatry Research ... 2000
Zhang ZF, Morgenstern H, ... Marijuana use and increased risk of squamous cell carcinoma of the hea... Cancer Epidemiol Bio... 2000
Yasui N, Kondo T, Furukor... Effects of repeated ingestion of grapefruit juice on the single and mu... Psychopharmacology (... 2000
Kraft M, Spahn TW, Menzel... [Fulminant liver failure after administration of the herbal antidepres... Dtsch Med Wochenschr 2001
Roth MD, Marques-Magallan... Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 ... Am J Respir Cell Mol... 2001
Nordgren HK, Beck O Direct screening of urine for MDMA and MDA by liquid chromatography-ta... J Anal Toxicol 2003
Atkins D, Best D, Briss P... Grading quality of evidence and strength of recommendations BMJ 2004
Zarate CA, Singh JB, Carl... A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-... Arch Gen Psychiatry 2006
Hashibe M, Morgenstern H,... Marijuana use and the risk of lung and upper aerodigestive tract cance... Cancer Epidemiol Bio... 2006
Maeng S, Zarate CA, Du J,... Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine:... Biol Psychiatry 2007
Jager G, de Win MM, Verva... Incidental use of ecstasy: no evidence for harmful effects on cognitiv... Psychopharmacology (... 2007
Tashkin DP Does smoking marijuana increase the risk of chronic obstructive pulmon... CMAJ 2009
Kuchkarov UI, Ashurov ZSh... [Efficiency of noophen in heroin addiction] Lik Sprava 2009
Tashkin DP Does cannabis use predispose to chronic airflow obstruction? Eur Respir J 2010
Tashkin DP Effects of marijuana smoking on the lung Ann Am Thorac Soc 2013
Kerr T, Small W, Hyshka E... 'It's more about the heroin': injection drug users' response to an ove... Addiction 2013
Huang YH, Zhang ZF, Tashk... An epidemiologic review of marijuana and cancer: an update Cancer Epidemiol Bio... 2015
Savage KM, Stough CK, Byr... Kava for the treatment of generalised anxiety disorder (K-GAD): study ... Trials 2015
Caldwell HK, Albers HE Oxytocin, Vasopressin, and the Motivational Forces that Drive Social B... Curr Top Behav Neuro... 2015
Csete J, Kamarulzaman A, ... Public health and international drug policy Lancet 2016
Botticelli MP, Koh HK Changing the Language of Addiction JAMA 2016